Gerresheimer earns EcoVadis Gold: Gerresheimer stock sits 8.53 percent below its high
Published on 10/14/2026 at 13:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSignals and scheduled reports
- EcoVadis raised Gerresheimer's score to 82 out of 100 on October 14, 2026.
- Second-quarter 2026 revenue reached EUR 578 million and adjusted EBITDA EUR 102 million.
- Gerresheimer stock trades at EUR 29.27 at 1:25 p.m. CEST at Lang & Schwarz on October 14, 2026, 0.72 percent above the Xetra close of October 13, 2026 at EUR 29.06.
Gerresheimer (ISIN DE000A0LD6E6) earned EcoVadis Gold with a score of 82 out of 100 on October 14, 2026, while Gerresheimer stock stood at EUR 29.27, 8.53 percent below its 52-week high of EUR 32.00, according to Deutsche Börse. The score rose from 78 in 2025, placing the pharmaceutical packaging group among the top 5 percent of all rated companies and the top 2 percent in its industry.
What does the rating add?
The sustainability result gives Gerresheimer a current operating indicator beyond its earnings recovery. The company also ranked in the top 1 percent of its industry for sustainable procurement, according to Deutsche Börse. That assessment does not change the earnings picture, but it adds a measurable customer and supply-chain signal to the investment case.
Three milestones and their figures
On September 30, 2026, Gerresheimer reported preliminary second-quarter revenue of EUR 578 million and adjusted EBITDA of EUR 102 million, up EUR 55 million and EUR 35 million respectively from the first quarter, according to Gerresheimer. The adjusted EBITDA margin reached 17.60 percent in the quarter, 5.00 percentage points above the first quarter.
On October 1, 2026, Gerresheimer completed the sale of its US Centor business. The combined enterprise value of Centor and Primary Packaging Plastics was EUR 1.5 billion, and the proceeds are intended to reduce debt, according to Finanznachrichten. The Primary Packaging Plastics transaction is expected to close in the first half of 2027.
Reporting dates move into view
Gerresheimer's investor calendar lists the final first-half 2026 report for late November 2026 and the third-quarter 2026 results for December 2026, according to Gerresheimer. Those reports will test whether the second-quarter improvement can broaden beyond the Containment and Delivery Systems business, where first-half revenue reached EUR 604 million versus EUR 591 million a year earlier.
Stock remains below its yearly high
Gerresheimer was trading at EUR 29.27 at Lang & Schwarz on October 14, 2026 at 1:25 p.m. CEST, 0.72 percent above the Xetra close of October 13, 2026 at EUR 29.06. The 52-week range was EUR 14.83 to EUR 32.00, leaving the quote 8.53 percent below the high.
The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.
Gerresheimer stock facts
- Company: Gerresheimer AG
- ISIN: DE000A0LD6E6
- WKN: A0LD6E
- Ticker: GXI
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 14, 2026, 1:25 p.m. CEST): EUR 29.27
- Change versus Xetra close: plus 0.72 percent
- Xetra close (October 13, 2026): EUR 29.06
- Market capitalization: EUR 1.0 billion (as of October 14, 2026)
- 52-week range: EUR 14.83-EUR 32.00 (as of October 14, 2026)
- Sector / Industry: Health Care
Market context: Market report DAX.
